Evaxion Biotech (NASDAQ:EVAX) reported its Q4 earnings results on Wednesday, March 27, 2024 at 07:30 AM. Here’s what investors need to know about the announcement. EarningsEvaxion Biotech beat estimated earnings by 90.0%, reporting an EPS of $-0.16 versus an estimate of $-1.6. Revenue was up $73 thousand from the same period last year. Past Earnings PerformanceLast quarter the company missed on EPS by $0.2 which was followed by a 7.000000000000001% increase in the share price the next day. To track all earnings releases for Evaxion Biotech visit their earnings calendar here. This article was g…